1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Lung Typical Carcinoid Tumor: new trials by email Literature Review of Lung Typical Carcinoid Tumor trials Research Report on Lung Typical Carcinoid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors Incomplete Freund's Adjuvant, Octreotide Acetate, Sargramostim - Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor | Phase 1 | Completed | Roswell Park Cancer Institute | 19 | 2019-06-17 | 2026-02-06 |
Adenoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Pancreatic Diseases (1) · Pancreatic Neoplasms (1)
Acetates (1) · Colony-Stimulating Factors (1) · Octreotide (1) · Salts (1) · incomplete Freund's adjuvant (1) · montanide ISA 51 (1) · sargramostim (1)
Roswell Park Cancer Institute (1)
United States (1)
Jasmeet Kaur, MD (1)